New Ray Medicine International Holding Ltd., a company incorporated in Bermuda, has announced a proposed capital reorganisation. This restructuring will involve a share consolidation, capital reduction, and share sub-division, consolidating every ten issued and unissued existing shares of par value HK$0.05 into one consolidated share of par value HK$0.50. Subsequently, each authorised but unissued consolidated share will be subdivided into fifty new shares of par value HK$0.01 each. The move aims to address market price extremities in accordance with Hong Kong Stock Exchange rules.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。